Letrozole is an active drug ingredient that’s available as a generic medication. It comes as oral tablets that you’ll swallow. Letrozole is a hormone therapy for breast cancer. Read on to ...

APP will market Letrozole in 2.5 mg tablets. According to IMS data, sales of the branded product in the United States were approximately $619.4 million, with approximately 1,775,000 bottles of 30 ...

Letrozole Tablets are the generic version of Novartis' Femara® Tablets, an adjuvant treatment for postmenopausal women with hormone receptor-positive early stage breast cancer.

The aromatase inhibitor letrozole, by suppressing estrogen production, might improve the outcome after the discontinuation of tamoxifen therapy. A total of 5187 women were enrolled (median follow ...

Ranbaxy Laboratories Ltd on Monday announced the launch of Letrozole tablets 2.5 mg in the UK, Romania and France, on Day-1. Letrozole is an Antineoplastics, indicated for the treatment of breast ...